CDW Corp: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 4, 2022 and accepted by EDGAR at May 4, 2022, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $5.95bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $4.84bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $1.10bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $717.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $386.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $80.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $250.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $1.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $1.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 136,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | $380.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $41.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2022-01-01 to 2022-03-31 | $67.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-03-31 | $386.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $6.87bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $13.51bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $5.46bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2022-03-31 | $6.51bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $83.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-03-31 | $893.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001402057-22-000084. Last ingested by Listed: Nov 4, 2026, 16:25 ET. Listed shows no prices and gives no investment advice.